Wellington Shields & Co. LLC purchased a new position in MetLife, Inc. (NYSE:MET) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 3,656 shares of the financial services provider’s stock, valued at approximately $201,000.

Several other institutional investors have also added to or reduced their stakes in MET. Carroll Financial Associates Inc. boosted its position in MetLife by 5.8% in the second quarter. Carroll Financial Associates Inc. now owns 3,013 shares of the financial services provider’s stock worth $165,000 after buying an additional 166 shares in the last quarter. Wallington Asset Management LLC boosted its position in MetLife by 1.7% in the second quarter. Wallington Asset Management LLC now owns 101,559 shares of the financial services provider’s stock worth $5,580,000 after buying an additional 1,720 shares in the last quarter. Gilbert & Cook Inc. acquired a new position in MetLife during the second quarter worth $211,000. Quantitative Systematic Strategies LLC boosted its position in MetLife by 8.4% in the second quarter. Quantitative Systematic Strategies LLC now owns 51,269 shares of the financial services provider’s stock worth $2,823,000 after buying an additional 3,984 shares in the last quarter. Finally, Private Bank & Trust Co. boosted its position in MetLife by 31.9% in the second quarter. Private Bank & Trust Co. now owns 15,675 shares of the financial services provider’s stock worth $861,000 after buying an additional 3,791 shares in the last quarter. Institutional investors and hedge funds own 74.83% of the company’s stock.

Shares of MetLife, Inc. (MET) traded up 0.15% during trading on Friday, hitting $46.81. The stock had a trading volume of 6,437,764 shares. The stock has a 50-day moving average of $48.80 and a 200 day moving average of $47.31. MetLife, Inc. has a 12-month low of $35.64 and a 12-month high of $51.77. The firm has a market cap of $49.75 billion, a price-to-earnings ratio of 550.71 and a beta of 1.46.

MetLife (NYSE:MET) last issued its earnings results on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.28 by $0.02. MetLife had a return on equity of 8.51% and a net margin of 0.30%. The company had revenue of $17.39 billion during the quarter, compared to the consensus estimate of $17.11 billion. During the same quarter in the prior year, the business earned $0.83 earnings per share. The company’s revenue was up 2.5% compared to the same quarter last year. On average, analysts predict that MetLife, Inc. will post $4.91 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 13th. Stockholders of record on Monday, August 7th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 3.42%. The ex-dividend date is Thursday, August 3rd. MetLife’s payout ratio is 1,777.98%.

ILLEGAL ACTIVITY NOTICE: “Wellington Shields & Co. LLC Purchases New Stake in MetLife, Inc. (NYSE:MET)” was originally published by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The legal version of this report can be accessed at https://www.dailypolitical.com/2017/08/12/wellington-shields-co-llc-purchases-new-stake-in-metlife-inc-nysemet.html.

A number of research firms have recently weighed in on MET. Barclays PLC lowered their price target on MetLife from $67.00 to $60.00 and set an “overweight” rating for the company in a report on Friday. ValuEngine upgraded MetLife from a “buy” rating to a “strong-buy” rating in a report on Friday. Zacks Investment Research cut MetLife from a “hold” rating to a “sell” rating in a report on Wednesday. BidaskClub upgraded MetLife from a “sell” rating to a “hold” rating in a report on Wednesday. Finally, Argus lowered their price target on MetLife from $60.00 to $55.00 and set a “buy” rating for the company in a report on Wednesday. Two analysts have rated the stock with a sell rating, six have issued a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $59.17.

About MetLife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.